Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the “Bernese method&rdquo

Autor: Hämmig R, Kemter A, Strasser J, von Bardeleben U, Gugger B, Walter M, Dürsteler KM, Vogel M

Publikováno v: Substance Abuse and Rehabilitation, Vol 2016, Iss Issue 1, Pp 99-105 (2016)

Robert Hämmig,1 Antje Kemter,2 Johannes Strasser,2 Ulrich von Bardeleben,1 Barbara Gugger,1 Marc Walter,2 Kenneth M Dürsteler,2 Marc Vogel2 1Division of Addiction, University Psychiatric Services Bern, Bern, Switzerland; 2Division of Substance Use

Externí odkaz: https://doaj.org/article/e53692168cd74d08bb85d40e1c0049e4

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Neurocognitive performance of patients undergoing intravenous versus oral opioid agonist treatment: a prospective multicenter study on three-month treatment effects.

Autor: Chamakalayil S; Faculty of Medicine, University of Basel, Basel, Switzerland., Stohler R; Psychiatric Practice Aquila, Pratteln, Switzerland., Moldovanyi A; Psychiatric Practice Aquila, Pratteln, Switzerland., Gerber M; Division of Sport and Psychosocial Health, Department of Sport, Exercise, and Health, University of Basel, Basel, Switzerland., Brand S; Division of Sport and Psychosocial Health, Department of Sport, Exercise, and Health, University of Basel, Basel, Switzerland.; Substance Abuse Prevention Research Center, Kermanshah University of Medical Sciences (KUMS), Kermanshah, Iran.; Sleep Disorders Research Center, Kermanshah University of Medical Sciences (KUMS), Kermanshah, Iran.; Center for Affective, Stress and Sleep Disorders, Psychiatric University Clinics Basel, University of Basel, Basel, Switzerland.; School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran.; Center for Disaster Psychiatry and Disaster Psychology, Psychiatric University Clinics Basel (UPK), University of Basel, Basel, Switzerland., Dürsteler KM; Division of Substance Use Disorders, Psychiatric University Clinics Basel, Basel, Switzerland.; Department for Psychiatry, Psychotherapy and Psychosomatic, Psychiatric Hospital, University of Zurich, Zurich, Switzerland.

Publikováno v: Frontiers in psychiatry [Front Psychiatry] 2024 Jul 23; Vol. 15, pp. 1375895. Date of Electronic Publication: 2024 Jul 23 (Print Publication: 2024).

Nomophobia (No Mobile Phone Phobia) and Psychological Health Issues among Young Adult Students.

Autor: Abdoli N; Substance Abuse Prevention Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6719851115, Iran., Sadeghi-Bahmani D; Department of Psychology, Stanford University, Stanford, CA 94305, USA.; Department of Epidemiology and Population Health, Stanford University, Stanford, CA 94305, USA., Salari N; Department of Biostatistics, School of Health, Kermanshah University of Medical Sciences, Kermanshah 6719851115, Iran.; Sleep Disorders Research Center, Kermanshah University of Medical Sciences, Kermanshah 6719851115, Iran., Khodamoradi M; Substance Abuse Prevention Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6719851115, Iran., Farnia V; Substance Abuse Prevention Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6719851115, Iran., Jahangiri S; Substance Abuse Prevention Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6719851115, Iran., Brühl AB; Center for Affective, Stress and Sleep Disturbances, Psychiatric Clinics of the University of Basel, 4002 Basel, Switzerland., Dürsteler KM; Division of Substance Use Disorders, Psychiatric Clinics of the University of Basel, 4002 Basel, Switzerland.; Department for Psychiatry, Psychotherapy and Psychosomatic, Psychiatric Hospital, University of Zurich, 8001 Zurich, Switzerland., Stanga Z; Centre of Competence for Military and Disaster Medicine, Swiss Armed Forces, 3008 Bern, Switzerland., Brand S; Substance Abuse Prevention Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6719851115, Iran.; Department of Epidemiology and Population Health, Stanford University, Stanford, CA 94305, USA.; Center for Affective, Stress and Sleep Disturbances, Psychiatric Clinics of the University of Basel, 4002 Basel, Switzerland.; Division of Sport Science and Psychosocial Health, Department of Sport, Exercise, and Health, Faculty of Medicine, University of Basel, 4052 Basel, Switzerland.; School of Medicine, Tehran University of Medical Sciences, Teheran 1417466191, Iran.; Center for Disaster Psychiatry and Disaster Psychology, Psychiatric Clinics of the University of Basel, 4002 Basel, Switzerland.

Publikováno v: European journal of investigation in health, psychology and education [Eur J Investig Health Psychol Educ] 2023 Sep 12; Vol. 13 (9), pp. 1762-1775. Date of Electronic Publication: 2023 Sep 12.

Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study.

Autor: Meyer M; University of Basel Psychiatric Clinics, University of Basel, Wilhelm Klein-Strasse 27, 4002, Basel, Switzerland. maximilian.meyer@upk.ch., Gygli F; University of Basel Psychiatric Clinics, University of Basel, Wilhelm Klein-Strasse 27, 4002, Basel, Switzerland.; Cantonal Hospital Baden, Baden, Switzerland., Westenberg JN; University of Basel Psychiatric Clinics, University of Basel, Wilhelm Klein-Strasse 27, 4002, Basel, Switzerland., Schmid O; University of Basel Psychiatric Clinics, University of Basel, Wilhelm Klein-Strasse 27, 4002, Basel, Switzerland., Strasser J; University of Basel Psychiatric Clinics, University of Basel, Wilhelm Klein-Strasse 27, 4002, Basel, Switzerland., Lang UE; University of Basel Psychiatric Clinics, University of Basel, Wilhelm Klein-Strasse 27, 4002, Basel, Switzerland., Dürsteler KM; University of Basel Psychiatric Clinics, University of Basel, Wilhelm Klein-Strasse 27, 4002, Basel, Switzerland.; Department for Psychiatry, Psychotherapy and Psychosomatic, Psychiatric Hospital, University of Zurich, Zurich, Switzerland., Vogel M; University of Basel Psychiatric Clinics, University of Basel, Wilhelm Klein-Strasse 27, 4002, Basel, Switzerland.

Publikováno v: Addiction science & clinical practice [Addict Sci Clin Pract] 2023 Jul 18; Vol. 18 (1), pp. 43. Date of Electronic Publication: 2023 Jul 18.